Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Legend Biotech ADR | LEGN | Dec 26, 2024 | 32.78 | -0.06 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Dec 26, 2024 | 38.95 | -0.03 |
Leggett & Platt | LEG | Dec 26, 2024 | 9.63 | -0.93 |
Leidos | LDOS | Dec 26, 2024 | 145.71 | +0.09 |
Leishen Energy Holding Co., Ltd. - Ordinary Shares | LSE | Dec 26, 2024 | 4.70 | 0.00 |
LeMaitre Vascular | LMAT | Dec 26, 2024 | 94.04 | +1.52 |
Lemonade | LMND | Dec 26, 2024 | 44.16 | +7.00 |
LendingClub | LC | Dec 26, 2024 | 17.27 | +3.66 |
LendingTree | TREE | Dec 26, 2024 | 40.29 | +4.81 |
Lendway | LDWY | Dec 26, 2024 | 4.99 | +9.91 |
Lennar A | LEN | Dec 26, 2024 | 138.64 | +0.46 |
Lennar B | LEN-B | Dec 26, 2024 | 134.53 | +0.27 |
Lennox International | LII | Dec 26, 2024 | 629.64 | -0.24 |
LENSAR | LNSR | Dec 26, 2024 | 8.37 | -3.68 |
LENZ Therapeutics | LENZ | Dec 26, 2024 | 32.01 | +1.62 |
Leonardo DRS | DRS | Dec 26, 2024 | 33.07 | +0.15 |
Lesaka Technologies | LSAK | Dec 26, 2024 | 5.35 | +3.68 |
Leslies | LESL | Dec 26, 2024 | 2.27 | +4.13 |
Levi Strauss & Co A | LEVI | Dec 26, 2024 | 17.47 | +0.17 |
Lexaria Bioscience | LEXX | Dec 26, 2024 | 2.37 | +7.24 |
Lexeo Therapeutics | LXEO | Dec 26, 2024 | 6.78 | +6.77 |
Lexicon Pharmaceuticals | LXRX | Dec 26, 2024 | 0.78 | +3.56 |
LexinFintech ADR | LX | Dec 26, 2024 | 6.32 | +4.64 |
LG Display ADR | LPL | Dec 26, 2024 | 3.24 | -5.26 |
LGI Homes | LGIH | Dec 26, 2024 | 91.02 | +0.72 |
LGL Group | LGL | Dec 26, 2024 | 5.89 | -4.23 |
Li Auto ADR | LI | Dec 26, 2024 | 25.32 | +3.60 |
Li Bang International | LBGJ | Dec 26, 2024 | 3.24 | 0.00 |
Li-Cycle | LICY | Dec 26, 2024 | 1.75 | +11.47 |
Liberty Allstar Equity Fund | USA | Dec 26, 2024 | 7.07 | +0.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.